Biotechnology firm INmune Bio Inc. (NASDAQ: INMB) and photonic quantum developer Quantum Computing Inc. (NASDAQ: QUBT) have ...

Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the third quarter 2026 before market open on ...

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the biotechnology industry, ...

Siren Biotechnology, a clinical-stage biotechnology company pioneering Universal AAV Immuno-Gene Therapy for cancer, today ...

Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and ...

Vir Biotechnology, entered a collaboration and license agreement with Gilead to discover and engineer three novel PRO-XTEN dual-masked T-cell engager development candidates target ...

Vir Biotechnology Inc. VIR announced a major collaboration with Gilead Sciences Inc. GILD to create three novel T-cell ...

Nigeria's Minister of Education says biotechnology is a critical tool for tackling food insecurity, malnutrition, and ...

T-cell engagers are designed to direct the body's immune system to recognize and attack cancer cells. Vir's PRO-XTEN technology is intended to keep these therapies inactive until they reach the tumor ...

PDS Biotechnology (PDSB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings ...

UK-based deep-tech ingredient solutions company MicroLub has secured US$10M to scale up its fat-replacement biotechnology, ...